EUpolicy

Market Access

Beyond Market Access: Why healthcare-system understanding is...

Healthcare-system literacy, and the ability to contribute to system shaping, must become part of how healthcare leaders make decisions.

News

Pharma leaders urge Europe to halt 'slow agony' of decline

Europe's top pharma firms have called on governments to take action to change the region's story from one of decay to one of "renewal and resilience."

Market Access

pharmaphorum podcast Episode 275, Giancarlo Benelli, BeOne Medicines

Europe for life sciences and for patients, with BeOne Medici...

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Giancarlo Benelli, SVP & Head of Europe at BeOne Medicines.

Market Access

The EU Joint Clinical Assessment in practice: Early lessons

Unfortunately, much of the discussion around the JCA has focused on how the framework is intended to operate, rather than how it works in practice.

Market Access

Europe’s new HTA reality: The JCA, one year on

Here, we examine the early realities of JCA implementation, exploring whether the system is delivering greater alignment across European markets.

News

Novo Nordisk wins Netherlands GLP-1 compounding lawsuit

A Dutch compounding pharmacy has been ordered to stop distributing a compounded nasal spray version of Novo Nordisk's GLP-1 agonist semaglutide.

Beyond Market Access: Why healthcare-system understanding is...

Pharma leaders urge Europe to halt 'slow agony' of decline

Europe for life sciences and for patients, with BeOne Medici...

The EU Joint Clinical Assessment in practice: Early lessons

Europe’s new HTA reality: The JCA, one year on

Novo Nordisk wins Netherlands GLP-1 compounding lawsuit

Iambic prices its IPO, seeking to raise up to $160m

Discover a new era of healthcare panel engagement: Grounded ...

EUpolicy

Editor's Picks